Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942009000400008
Brazilian Journal of Anesthesiology
Scientific Article

Efeito analgésico de antagonistas do receptor da histamina H1 em modelo de dor provocada por formalina em ratos

Analgesic effects of H1 receptor antagonists in the rat model of formalin-induced pain

Hazem Adel Ashmawi; Leandro Mamede Braun; Angela Maria Sousa; Irimar de Paula Posso

http://dx.doi.org/10.1590/S0034-70942009000400008 Braz J Anesthesiol, vol.59, n4, p.461-470, 2009
PDF Português
PDF English
Downloads: 0
Views: 1263

Resumo

JUSTIFICATIVA E OBJETIVOS: Os receptores de histamina mediam vias nociceptivas principalmente no sistema nervoso central. Alguns estudos mostraram efeito analgésico de antagonistas de receptor de histamina no sistema nervoso periférico. Não está claro se o efeito analgésico local é classe específico ou droga específico. MÉTODO: Para responder a essa questão, utilizamos três diferentes antagonistas do receptor H1 (pirilamina, prometazina e cetirizina) administrados diretamente na pata do rato, pela via intraperitoneal ou por bloqueio de nervo periférico em modelo de dor induzida por formalina. Observamos o efeito das drogas no comportamento do número de elevações da pata. RESULTADOS: Na fase I, a pirilamina local diminuiu o número de elevações da pata de forma dose-dependente. Na dose mais alta, a diminuição foi de 97,8%. Para a prometazina, a diminuição foi de 92% e para cetizirina, 23,9%. Na fase II, a pirilamina diminuiu o número de elevações da pata em 93,5%, a prometazina em 78,2% e a cetirizina em 80,1%. A administração dos fármacos por via intraperitoneal não alterou o comportamento doloroso. Quando utilizadas para bloqueio de nervo periférico, na fase I, a pirilamina diminuiu o número de elevações da pata em 96,7%, a prometazina em 73,3% e a cetirizina em 23,9%. Na fase II, a pirilamina levou à diminuição de 86,6%, a prometazina de 64,4% e a cetirizina de 19,9%. CONCLUSÕES: Os resultados mostraram que os antagonistas de receptor da histamina H1 apresentam efeitos analgésicos locais, diferentes do efeito sistêmico, sendo um deles anti-inflamatório e classe específico e o outro específico para prometazina e pirilamina, semelhante a efeito clínico anestésico local.

Palavras-chave

ANIMAIS, DOR, Experimental, DROGAS, DROGAS, DROGAS

Abstract

BACKGROUND AND OBJECTIVES: Histamine receptors mediate nociceptive pathways, especially in the central nervous system. Some studies have demonstrated the analgesic effects of histamine receptor antagonists in the peripheral nervous system. It is not clear whether the local analgesic effect is class-specific or drug-specific. METHODS: To answer this question, we used three different H1 receptor antagonists (pyrilamine, promethazine, and cetirizine) administered directly in the paw of the rat, intraperitoneally, or in peripheral nerve blockade in the formalin-induced pain model. The effects of the drugs on the number of paw elevations were observed. RESULTS: In phase I, the local administration of pyrilamine caused a dose-dependent reduction on the number of paw elevations; in the highest dose, the number of paw elevations was reduced by 97.8%. Promethazine decreased it by 92%, while cetirizine decreased by 23.9%. In phase II, pyrilamine decreased the number of paw elevations by 93.5%, promethazine by 78.2%, and cetirizine by 80.1%. Intraperitoneal administration of drugs did not change painful behavior. When used in peripheral nerve block, in phase I pyrilamine reduced the number of paw elevations by 96.7%, promethazine by 73.3%, and cetirizine by 23.9%. In phase II, pyrilamine reduced the number of paw elevations by 86.6%, promethazine by 64.4%, and cetirizine by 19.9%. CONCLUSIONS: The results demonstrate that H1 receptor antagonists have local analgesic effects, different from the systemic effects, one of them an anti-inflammatory and class-specific effect and the other similarly to the local anesthetic effect, specific for promethazine and pyrilamine

Keywords

ANIMALS, DRUGS, DRUGS, pyrilamine, PAIN, Experimental

Referencias

Raffa RB. Antihistamines as analgesics. J Clin Pharm Ther. 2001;26:81-85.

Ash AS, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol Chemother. 1966;27:427-429.

Soll AH, Walsh JH. Regulation of gastric acid secretion. Annu Rev Physiol. 1979;41:35-53.

Schwartz JC, Arrang JM, Garbarg M. Histaminergic transmission in the mammalian brain. Physiol Rev. 1991;71:1-51.

Oda T, Morikawa N, Saito Y. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem. 2000;275:36781-36786.

Hofstra CL, Desai PJ, Thurmond RL. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther. 2003;305:1212-1221.

Chung YH, Miyake H, Kamei C. Analgesic effect of histamine induced by intracerebral injection into mice. Agents Actions. 1984;15:137-142.

Malmberg-Aiello P, Lamberti C, Ghelardini C. Role of histamine in rodent antinociception. Br J Pharmacol. 1994;111:1269-1279.

Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Progr Neurobiol. 2001;63:637-672.

Galeotti N, Malmberg-Aiello P, Bartolini A. H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. Neuropharmacology. 2004;47:295-303.

Thoburn KK, Hough LB, Nalwalk JW. Histamine-induced modulation of nociceptive responses. Pain. 1994;58:29-37.

Abacioglu N, Bediz A, Çakici I. Antinociceptive effects of H1- and H2- antihistaminics in mice. Gen Pharmac. 1993;24:1173-1176.

Passani MB, Lin JS, Hancock A. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci. 2004;25:618-625.

Parada CA, Tambeli CH, Cunha FQ. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience. 2001;102:937-944.

Ashmawi HA, Chambergo FS, Palmeira CCA. Effects of pyrilamine and cimetidine on mRNA c-fos expression and nociceptive behaviour in rats. Anesth Analg. 2003;97:541-546.

Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109-110.

Wall PD. Vigilance in defense of animal welfare. Pain. 1993;54:239.

Shibata M, Ohkubo T, Takahashi H. Modified formalin test: characteristic biphasic pain response. Pain. 1989;38:347-352.

Wheeler-Aceto H, Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology. 1991;104:35-44.

Doak GJ, Sawinok J. Formalin induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxitryptamine receptor subtypes. Neuroscience. 1997;80:939-949.

Dubuisson D, Dennis SG. The formalin test: a quantitative study of analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4:161-174.

Sousa AM, Franco PAB, Ashmawi HA. Efeito analgésico local do tramadol em modelo de dor provocada por formalina em ratos. Rev Bras Anestesiol. 2008;58:371-379.

Taylor BK, Peterson MA, Basbaum AI. Persistent cardiovascular and behavioural nociceptive responses to subcutaneous formalin require peripheral nerve input. J Neurosci. 1995;15:7575-7584.

Teng CJ, Abbott FV. The formalin test: a dose-response analysis at three developmental stages. Pain. 1998;76:337-347.

Malmberg-Aiello P, Lamberti C, Ipponi A. Evidence of hypernociception induction following histamine H1 receptor activation in rodents. Life Sci. 1998;63:463-476.

Thurmond RL, Desai PJ, Dunford PJ. A potent and selective histamine H4 receptor antagonists with anti-inflammatory properties. J Pharmacol Exp Ther. 2004;309:404-413.

Sakurada S, Watanabe H, Mizoguchi H. Involvement of the histaminergic system in the nociceptin-induced pain-related behaviors in the mouse spinal cord. Pain. 2004;112:171-182.

Coderre TJ, Vacarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 1990;535:155-158.

Tjÿlsen A, Berge OG, Rosland JH. The formalin test: an evaluation of the method. Pain. 1992;51:5-17.

Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987;30:103-114.

Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 1996;64:345-355.

Rumore MM, Schlichting DA. Analgesic effects of antihistaminics. Life Sci. 1985;36:403-416.

5dd678e30e8825741fc8fca7 rba Articles
Links & Downloads
2352-2291 (Electrónico) 0104-0014 (Impreso)
Braz J Anesthesiol ©2024 Todos los derechos reservados.

Braz J Anesthesiol

Share this page
Page Sections